Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Colorectal cancer burden rises in younger age groups

Key clinical point: Current trends in the incidence and mortality of colorectal cancer in the United States suggest the disease will become one that largely affects young and middle-aged adults.

Major finding: Among individuals aged 65 years or older, colorectal cancer incidence dropped by 3.3% per year from 2011 through 2016, but the incidence accelerated in individuals aged 50-64 years (1% per year) and those younger than 50 years (2.2% per year).

Study details: A population-based cohort study using Surveillance, Epidemiology, and End Results registry data through 2017.

Disclosures: The authors disclosed financial affiliations with the American Cancer Society, which funded the study, as well as Array Biopharma, Bayer, RGenix, Tesaro, and Seattle Genetics.


Siegel RL et al. CA Cancer J Clin. 2020 Mar 5. doi: 10.3322/caac.21601.